Why Heron Therapeutics Stock Popped in July

What happened
Shares of Heron Therapeutics(NASDAQ:HRTX), a small-cap drugmaker, gained 10.7% over the course of July, according to data provided by S&P Global Market Intelligence. The biotech’s shares seemingly benefited from a wave of bargain buying last month following the company’s sharp pullback in June.
In late June, Heron’s stock took a big step backward in response to a Complete Response Letter from the Food and Drug Administration (FDA) for its non-opioid painkiller Zynrelef, also …

Click here to view the original article.